Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-ESPB vs FICB for Postoperative Analgesia in THA
NCT05905510Phase 4Unknown
- Sponsor
- Tanta University
- Start
- Jun 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine in postoperative pain (3 arms), sponsored by Tanta University. Primary endpoint: Assessment of postoperative pain at 24 hours. Status: unknown.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05905510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05905510.